{"title":"Risk vs. Benefit Analysis of Ultraviolet-C Advanced Aircraft Disinfection.","authors":"Gary R Allen, William D Mills, Diego M Garcia","doi":"10.3357/AMHP.6351.2025","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This work provides details and references that help to quantify the benefits of using ultraviolet-C (UV-C) light for air disinfection in aircraft vs. the risk of overexposure to UV-C for passengers and crew. The analysis estimates that due to the combined transmission of Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A aboard commercial aircraft in the United States over the 3 yr through May 2023, there were on the order of 10,000 annual deaths, declining to 3,000/yr going forward, with an estimated annual economic burden of $200 billion. Up to 80% of the deaths and economic burden might be saved by supplementing the typical 30 air changes per hour of the aircraft ventilation system with a presently available 120 air changes per hour, using a UV-C disinfection system. The risks due to accidental overexposure to UV-C are orders of magnitude lower than the benefits. The 0.00003% risk of acute (one-time) overexposure for any given passenger may (or may not) result in a 1-2-day skin or eye irritation, with no long-term effects or risks, compared to the 15,000 times greater risk, at 0.5%, of contracting coronavirus disease 19 or Influenza A that persists for several days to weeks, and carries a risk of hospitalization or death. The estimated risk of non-melanoma skin cancer is virtually nil. Allen GR, Mills WD, Garcia DM. Risk vs. benefit analysis of ultraviolet-C advanced aircraft disinfection. Aerosp Med Hum Perform. 2025; 96(3S):A1-A32.</p>","PeriodicalId":7463,"journal":{"name":"Aerospace medicine and human performance","volume":"96 3S","pages":"A1-A32"},"PeriodicalIF":0.9000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aerospace medicine and human performance","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3357/AMHP.6351.2025","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: This work provides details and references that help to quantify the benefits of using ultraviolet-C (UV-C) light for air disinfection in aircraft vs. the risk of overexposure to UV-C for passengers and crew. The analysis estimates that due to the combined transmission of Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A aboard commercial aircraft in the United States over the 3 yr through May 2023, there were on the order of 10,000 annual deaths, declining to 3,000/yr going forward, with an estimated annual economic burden of $200 billion. Up to 80% of the deaths and economic burden might be saved by supplementing the typical 30 air changes per hour of the aircraft ventilation system with a presently available 120 air changes per hour, using a UV-C disinfection system. The risks due to accidental overexposure to UV-C are orders of magnitude lower than the benefits. The 0.00003% risk of acute (one-time) overexposure for any given passenger may (or may not) result in a 1-2-day skin or eye irritation, with no long-term effects or risks, compared to the 15,000 times greater risk, at 0.5%, of contracting coronavirus disease 19 or Influenza A that persists for several days to weeks, and carries a risk of hospitalization or death. The estimated risk of non-melanoma skin cancer is virtually nil. Allen GR, Mills WD, Garcia DM. Risk vs. benefit analysis of ultraviolet-C advanced aircraft disinfection. Aerosp Med Hum Perform. 2025; 96(3S):A1-A32.
期刊介绍:
The peer-reviewed monthly journal, Aerospace Medicine and Human Performance (AMHP), formerly Aviation, Space, and Environmental Medicine, provides contact with physicians, life scientists, bioengineers, and medical specialists working in both basic medical research and in its clinical applications. It is the most used and cited journal in its field. It is distributed to more than 80 nations.